Cargando…
Therapeutic Antibodies in Stroke
Immunotherapy represents an active area of biomedical research to treat cancer, autoimmune diseases, and neurodegenerative disorders. In stroke, recanalization therapy is effective in reducing brain tissue damage after acute ischemic stroke. However, the narrow time window restricts its application...
Autores principales: | Yu, Chye Yun, Ng, Gandi, Liao, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787786/ https://www.ncbi.nlm.nih.gov/pubmed/24098313 http://dx.doi.org/10.1007/s12975-013-0281-2 |
Ejemplares similares
-
TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke
por: Chen, Bo, et al.
Publicado: (2019) -
Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice
por: Qiu, Lifeng, et al.
Publicado: (2016) -
Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury
por: Chen, Bo, et al.
Publicado: (2018) -
Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment
por: Gandi, Carlo, et al.
Publicado: (2021) -
Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke
por: Dewan, Shyam N., et al.
Publicado: (2017)